OBJECTIVES: This study sought to describe the results of transcatheter tricuspid valve-in-ring (TVIR) implantation for treatment of tricuspid regurgitation (TR). BACKGROUND: Off-label use of transcatheter valves within surgically placed tricuspid annuloplasty prostheses has only been described in small reports. An international multicenter registry was developed to collect data on TVIR implantation. METHODS: Data were collected from 13 sites on 22 patients (5 to 69 years of age) with TR who underwent catheterization with the intent to perform TVIR implantation. RESULTS: TVIR implantation was performed in 20 patients (91%). Most patients were severely impaired (86% in New York Heart Association functional class III or IV); TR was severe in 8...
Tricuspid valve regurgitation is both globally prevalent and undertreated. Historically, surgical in...
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impac...
BACKGROUND AND AIMS For patients with symptomatic, severe tricuspid regurgitation (TR), early res...
OBJECTIVES The aim of this registry was to evaluate the feasibility and safety of transcatheter tric...
OBJECTIVES: This study sought to develop a large, international registry to evaluate the diffusion o...
Introduction: Transcatheter tricuspid valve (TV) procedures emerged as an alternative to surgery for...
Tricuspid regurgitation (TR) may affect as much as 65–85% of the population with the prevalence of m...
OBJECTIVES A large, prospective international registry was developed to evaluate the initial clin...
OBJECTIVES: Tricuspid regurgitation (TR) secondary to left heart disease is the most common aetiolog...
Tricuspid regurgitation (TR) is a common valvular heart disease affecting >1.6 million people in ...
AbstractBackgroundIsolated tricuspid valve surgery is associated with high morbidity and mortality, ...
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which ge...
OBJECTIVES A large, prospective international registry was developed to evaluate the initial clinic...
SummaryBackgroundTranscatheter valve-in-valve (VIV) implantation in failing bioprosthesis is an emer...
Background Medically managed tricuspid regurgitation (TR) has detrimental outcomes. Transcatheter t...
Tricuspid valve regurgitation is both globally prevalent and undertreated. Historically, surgical in...
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impac...
BACKGROUND AND AIMS For patients with symptomatic, severe tricuspid regurgitation (TR), early res...
OBJECTIVES The aim of this registry was to evaluate the feasibility and safety of transcatheter tric...
OBJECTIVES: This study sought to develop a large, international registry to evaluate the diffusion o...
Introduction: Transcatheter tricuspid valve (TV) procedures emerged as an alternative to surgery for...
Tricuspid regurgitation (TR) may affect as much as 65–85% of the population with the prevalence of m...
OBJECTIVES A large, prospective international registry was developed to evaluate the initial clin...
OBJECTIVES: Tricuspid regurgitation (TR) secondary to left heart disease is the most common aetiolog...
Tricuspid regurgitation (TR) is a common valvular heart disease affecting >1.6 million people in ...
AbstractBackgroundIsolated tricuspid valve surgery is associated with high morbidity and mortality, ...
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which ge...
OBJECTIVES A large, prospective international registry was developed to evaluate the initial clinic...
SummaryBackgroundTranscatheter valve-in-valve (VIV) implantation in failing bioprosthesis is an emer...
Background Medically managed tricuspid regurgitation (TR) has detrimental outcomes. Transcatheter t...
Tricuspid valve regurgitation is both globally prevalent and undertreated. Historically, surgical in...
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impac...
BACKGROUND AND AIMS For patients with symptomatic, severe tricuspid regurgitation (TR), early res...